Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. 2010

Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
Department of Medical and Molecular Genetics, Kings College, London, SE1 9RT, UK.

Brown-Vialetto-Van Laere syndrome is a rare neurological disorder with a variable age at onset and clinical course. The key features are progressive ponto-bulbar palsy and bilateral sensorineural deafness. A complex neurological phenotype with a mixed picture of upper and lower motor neuron involvement reminiscent of amyotrophic lateral sclerosis evolves with disease progression. We identified a candidate gene, C20orf54, by studying a consanguineous family with multiple affected individuals and subsequently demonstrated that mutations in this gene were the cause of disease in other, unrelated families.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010244 Bulbar Palsy, Progressive A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. (Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115(Pt 6):1889-1900) Fazio-Londe Disease,Fazio-Londe Syndrome,Fazio-Londe's Disease,Fazio-Londe's Syndrome,Paralysis, Bulbar,Bulbar Palsy,Bulbar Palsy, Progressive, Of Childhood,Childhood Progressive Bulbar Palsy,Progressive Bulbar Palsy of Childhood,Bulbar Palsies,Bulbar Palsies, Progressive,Bulbar Paralyses,Bulbar Paralysis,Disease, Fazio-Londe,Disease, Fazio-Londe's,Fazio Londe Disease,Fazio Londe Syndrome,Fazio Londe's Disease,Fazio Londe's Syndrome,Palsies, Bulbar,Palsies, Progressive Bulbar,Palsy, Bulbar,Palsy, Progressive Bulbar,Progressive Bulbar Palsies,Syndrome, Fazio-Londe,Syndrome, Fazio-Londe's
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002890 Chromosomes, Human, Pair 20 A specific pair of GROUP F CHROMOSOMES of the human chromosome classification. Chromosome 20
D003638 Deafness A general term for the complete loss of the ability to hear from both ears. Deafness Permanent,Hearing Loss Permanent,Prelingual Deafness,Deaf Mutism,Deaf-Mutism,Deafness, Acquired,Hearing Loss, Complete,Hearing Loss, Extreme,Acquired Deafness,Complete Hearing Loss,Deafness, Prelingual,Extreme Hearing Loss,Permanent, Deafness,Permanent, Hearing Loss,Permanents, Deafness

Related Publications

Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
May 1981, Journal of the neurological sciences,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
February 1996, Indian pediatrics,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
September 2012, Journal of human genetics,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
September 2012, Journal of human genetics,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
April 2008, Orphanet journal of rare diseases,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
February 1993, Neuropathology and applied neurobiology,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
January 2024, Iranian journal of child neurology,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
March 1990, Journal of medical genetics,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
September 2013, Journal of pediatric neurosciences,
Peter Green, and Matthew Wiseman, and Yanick J Crow, and Henry Houlden, and Shelley Riphagen, and Jean-Pierre Lin, and F Lucy Raymond, and Anne-Marie Childs, and Eamonn Sheridan, and Sian Edwards, and Dragana J Josifova
June 2012, Pediatric neurology,
Copied contents to your clipboard!